Consumer beauty startup Antinorm has secured ₹28 crore in seed funding as it looks to deepen its science-first product portfolio and widen its market reach in India’s fast-evolving direct-to-consumer beauty segment. The round was led by Fireside Ventures, with V3 Ventures and Rukam Capital participating as returning investors, underscoring continued confidence in the brand’s early momentum.
The company plans to deploy the newly raised capital across research and product development, talent acquisition, and inventory and supply chain strengthening. Antinorm is focused on building formulations rooted in dermatological research while keeping pricing accessible for a broad consumer base. The funding will also help the brand accelerate go-to-market timelines for upcoming launches and scale distribution across digital platforms.
The investors backing Antinorm have remained active across consumer and lifestyle categories in recent months.
Fireside Ventures, which led the round, has continued to double down on consumer-focused startups. Its recent investments include Underneat, a shapewear brand, as well as growth-stage bets in health, wellness, and sports-led consumer companies such as The Good Bug and Sports for Life. The firm has consistently focused on brands that blend strong storytelling with operational depth.
V3 Ventures, known for its early-stage consumer bets, has recently led the seed round in clinical skincare brand Be Clinical and co-led the Series B funding for nutrition-focused startup SuperYou. Its participation in Antinorm reflects its ongoing interest in differentiated beauty and wellness brands.
Rukam Capital has also been actively expanding its consumer portfolio, with recent investments in fragrance startup Fraganote and personal care brand Koriken, among others.
With repeat backing from seasoned consumer investors, Antinorm’s latest fundraise positions it to move faster in a competitive market while staying anchored to product innovation and long-term brand building.